Your browser doesn't support javascript.
loading
CYP1A2 and tobacco interaction: a major pharmacokinetic challenge during smoking cessation.
Barrangou-Poueys-Darlas, Malcolm; Guerlais, Marylène; Laforgue, Edouard-Jules; Bellouard, Ronan; Istvan, Marion; Chauvin, Pascale; Guillet, Jean-Yves; Jolliet, Pascale; Gregoire, Matthieu; Victorri-Vigneau, Caroline.
Afiliação
  • Barrangou-Poueys-Darlas M; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
  • Guerlais M; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
  • Laforgue EJ; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
  • Bellouard R; Addictology and Psychiatry Department, University Hospital Centre Nantes, Nantes, France.
  • Istvan M; INSERM UMR 1246 SPHERE (methodS in Patients-centered outcomes and HEalth Research), Nantes and Tours Universities, Nantes, France.
  • Chauvin P; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
  • Guillet JY; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
  • Jolliet P; Addictology Regional Network (URAA), Structure Régionale d'Appui et d'Expertise Addictologie des Pays de la Loire, Nantes, France.
  • Gregoire M; Addictology Regional Network (URAA), Structure Régionale d'Appui et d'Expertise Addictologie des Pays de la Loire, Nantes, France.
  • Victorri-Vigneau C; Clinical Pharmacology Department, University Hospital Centre Nantes, Nantes, France.
Drug Metab Rev ; 53(1): 30-44, 2021 02.
Article em En | MEDLINE | ID: mdl-33325257

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abandono do Hábito de Fumar / Citocromo P-450 CYP1A2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Drug Metab Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Abandono do Hábito de Fumar / Citocromo P-450 CYP1A2 Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Drug Metab Rev Ano de publicação: 2021 Tipo de documento: Article País de afiliação: França